Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CODEXIS, INC.CDXS · Entity 6428 | Chief Scientific Officer | February 23, 2026 | February 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CODEXIS, INC.
Report date February 23, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 130,421 |
Reported balance
After 2026-02-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-24 · Sale · Disposed 5,862 · Balance 130,421 F1: The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units ("RSUs") of the Issuer. F2: Includes 23,299 RSUs. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.07 · Expires 2036-02-23 | Direct | 316,100 |
Reported balance
After 2026-02-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-23 · Grant · Acquired 316,100 · Balance 316,100 F3: This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units ("RSUs") of the Issuer.
F2: Includes 23,299 RSUs.
F3: This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2026 Filed Feb 26, 2026 00:54 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 5,862 | $1.13 | $6,641.06 |
DisclosureSEC source: 0001610717-26-000073 · form4.xml · nonDerivative · entry 1 Lutz Stefan · CIK 0002094828 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,421 F1 · kind: The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units ("RSUs") of the Issuer. F2 · balance_after: Includes 23,299 RSUs. Read SEC document |
| February 23, 2026 Filed Feb 26, 2026 00:54 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantStock Option (Right to Buy) · Derivative | 316,100 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001610717-26-000073 · form4.xml · derivative · entry 2 Lutz Stefan · CIK 0002094828 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,100 Underlying: Common Stock · 316,100 shares Expires 2036-02-23 F3 · derivative.exercise_date: This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates. Read SEC document |
| February 06, 2026 Filed Feb 9, 2026 21:07 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 2,492 | $1.31 | $3,257.29 |
DisclosureSEC source: 0001610717-26-000047 · form4.xml · nonDerivative · entry 1 Lutz Stefan · CIK 0002094828 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,283 F1 · kind: The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units ("RSUs") of the Issuer. F2 · balance_after: Includes 35,799 restricted stock units. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 23:51 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 4,685 | $1.70 | $7,949.51 |
DisclosureSEC source: 0001610717-26-000007 · form4.xml · nonDerivative · entry 1 Lutz Stefan · CIK 0002094828 · CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,775 F1 · kind: The sale reported on this Form 4 was effected to cover tax liability incurred due to the vesting and release of Restricted Stock Units held by the Reporting Person. F2 · balance_after: Includes 41,633 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.